1,009,000.00
+4000(+0.40%)
Currency In KRW
Address
300, Songdo Bio-daero
Incheon, 21987
Korea, Republic of
Phone
82 3 2455 3114
Website
Sector
Healthcare
Industry
Biotechnology
Employees
4770
First IPO Date
November 11, 2016
| Name | Title | Pay | Year Born |
| Mr. John Chongbo Rim | Chief Executive Officer, President & Chairman of Board | 6.6B | 1961 |
| Mr. James J. Choi | Executive Vice President, Head of CDO Development Center & Head of Sales Center | 569M | 1967 |
| Dr. Kun Lo Ph.D. | Executive Vice President, Head of EPCV Center & Director | 879.5M | 1963 |
| Mr. Dong-Joong Kim | EVice President & Head of Co-Prosperity Cooperation Center | 1.2B | 1965 |
| Mr. Seung ho Ryu | EVice President, Chief Financial Officer, Head of Business Support Center & Director | 0 | N/A |
| Yeowan Youn | Vice President & Head of Legal Compliance Team | 0 | N/A |
| Mr. Pierre Catignol | Executive Vice President & Head of Operation Center | 0 | 1968 |
| Mr. Kyuho Lee | Executive Vice President, Head of People Center, & Chief Human Resource Officer | 0 | N/A |
| Mr. Kevin Sharp | EVice President and Head of Sales & Operations Department | 0 | N/A |
| Dr. Brian Hosung Min Ph.D. | Executive Vice President & Head of CDO Development Center | 0 | N/A |
Samsung Biologics Co.,Ltd. engages in the contract manufacturing organization (CMO) business for biopharmaceuticals products. The company operates in two segments, CMO and Contract Development Organization (CDO). It is involved in the provision of CDO services, including cell line development, upstream and downstream processes, and analytical methods and formulations. The company also offers aseptic filling, lyophilization, finishing, storage and shipping, and support services; and quality assurance and control, as well as biosafety and analytical testing services. In addition, it engages in the development and commercialization of biosimilar drugs; and manufactures mammalian cell-based antibody drugs. The company was founded in 2011 and is headquartered in Incheon, South Korea.